Recent studies have shown the ability of mesenchymal stem cells (MSCs) to migrate toward and engraft into the tumor sites, which provides a potential for their use as carriers for cancer gene therapy. Here, we describe the strategies of using MSCs as carriers for cancer gene therapy using a nonviral transfection method.
CITATION STYLE
Hu, Y. L., & Gao, J. Q. (2014). Recombinant stem cells as carriers for cancer gene therapy. In Methods in Molecular Biology (Vol. 1141, pp. 103–108). Humana Press Inc. https://doi.org/10.1007/978-1-4939-0363-4_5
Mendeley helps you to discover research relevant for your work.